Good News for SCA27b

[wobblybee]

Solaxa has announced plans to conduct a phase 3 clinical trial of their drug SLX-100 (repurposed 4-Aminopyridine) for Spinocerebellar ataxia 27B (SCA27B). The trial will be based in the US, but additional trial sites are to be announced later this year.

Read more on our website.

#AtaxiaResearch #AtaxiaPharma #CerebellarAtaxia #SCA27b #Solaxa

[paul456]

Thanks Mrs Bee you’re the foundation of knowledge on this fantastic website 😊 x

[wobblybee in reply to paul456]

🙂I’m hoping…to be tested for SCA27b…when the test is available in the UK

[7151 in reply to wobblybee]

Interessted